Leili Mohebnasab: Understanding Placental Health Through Epigenetics
Leili Mohebnasab, Midwife at Shariati Hospital, shared a post on LinkedIn:
“Epigenetic Biomarkers of Placental Health:
What DNA Methylation Reveals—and Where It Must Remain Silent
For decades, placental health has been assessed indirectly—through fetal growth patterns, Doppler findings, and late clinical syndromes such as preeclampsia or preterm birth. These approaches detect outcomes, not the biological processes unfolding earlier in pregnancy.
Epigenetics offers a different perspective.
According to guidance and research priorities from the World Health Organization, NIH-supported placental biology programs, and CDC population health frameworks (2020–2025), epigenetic markers—particularly DNA methylation (DNAm)—reflect how the placenta adapts to its environment over time.
The placenta is epigenetically dynamic
Placental tissue undergoes rapid differentiation, immune modulation, and metabolic adaptation. NIH research shows that DNAm patterns shift predictably across gestation as part of normal development. These changes are not signs of damage—they are features of placental biology.
When timing appears altered
In some complicated pregnancies, placental DNAm patterns suggest biological ‘age acceleration,’ meaning the placenta appears epigenetically older than expected for gestational age. WHO emphasizes that this reflects cumulative biological stress—not inevitable pathology or outcome.
What epigenetic biomarkers can tell us
At the population level, altered DNAm patterns have been associated with placental insufficiency, fetal growth restriction, and hypertensive disorders of pregnancy. These associations deepen biological understanding but do not provide individual prediction.
What they cannot do
Global guidance is clear:
- epigenetic markers are not screening tools,
- they do not establish causality,
- they do not justify intervention in asymptomatic pregnancy.
A clinical and midwifery perspective
Epigenetic research reframes how we understand placental adaptation—but it does not change the foundations of care. Clinical assessment, physiological monitoring, and continuity remain central.
Epigenetics records responsiveness—not destiny.
WHO | NIH | CDC (2020–2025)
Question for you
How can we use epigenetic insight to improve understanding of placental health without turning adaptive biology into deterministic labels?”
Read more.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Jun 15, 2026, 12:21Zara Grigoryan: Open Expert Dialogue to Shape Women’s Health in Armenia
-
Jun 15, 2026, 12:12Abhishek Saxena։ Can a 5PN Embryo Develop Normally?
-
Jun 15, 2026, 12:02Does Growth Hormone Help in IVF? – Fertility Plus
-
Jun 15, 2026, 11:55Allen Morgan: PRP in Fertility Treatment, Emerging Evidence and Future Directions
-
Jun 15, 2026, 11:49Hereditary Gynecologic Cancer Care Is Evolving, but Access and Health Systems Remain Unequal – IJGO
-
Jun 15, 2026, 11:41Celebrating Community and Support at the Annual Fertili’Tea Party! – CFAS
-
Jun 15, 2026, 11:37Christopher Robinson: Outcomes in Late Preterm and Term Births with Gestational Diabetes vs Normoglycemia
-
Jun 15, 2026, 11:34Registration Now Open for Fertility 2027 – British Fertility Society
-
Jun 15, 2026, 11:28Ioakeim Sapantzoglou: Excited to Share Our Latest Publication in Archives of Gynecology and Obstetrics!